129 related articles for article (PubMed ID: 32064753)
21. Transcriptomic analysis of Porphyromonas gingivalis-infected head and neck cancer cells: Identification of PLAU as a candidate prognostic biomarker.
Hamada M; Inaba H; Nishiyama K; Yoshida S; Yura Y; Matsumoto-Nakano M; Uzawa N
J Cell Mol Med; 2024 Feb; 28(4):. PubMed ID: 38363001
[TBL] [Abstract][Full Text] [Related]
22. Circulating small non-coding RNA signature in head and neck squamous cell carcinoma.
Victoria Martinez B; Dhahbi JM; Nunez Lopez YO; Lamperska K; Golusinski P; Luczewski L; Kolenda T; Atamna H; Spindler SR; Golusinski W; Masternak MM
Oncotarget; 2015 Aug; 6(22):19246-63. PubMed ID: 26057471
[TBL] [Abstract][Full Text] [Related]
23. Y-Chromosome-Linked Genes Are Associated With Sex-Related Head-Neck Squamous Cell Carcinoma Survival.
Feng X; Zhang T; Chou J; Patwa HS; Sullivan CA; Browne JD
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1533-1541. PubMed ID: 37418217
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.
Feng X; Zhang T; Chou J; Liu L; Miller LD; Sullivan CA; Browne JD
Head Neck; 2022 Feb; 44(2):443-452. PubMed ID: 34841601
[TBL] [Abstract][Full Text] [Related]
25. The lncRNA XIST/miR-29b-3p/COL3A1 axis regulates central carbon metabolism in head and neck squamous cell carcinoma and is associated with poor tumor prognosis.
Li Q; Miao J; Shi N; Lin C; Hu X; Shen Y
Ann Transl Med; 2023 Feb; 11(4):165. PubMed ID: 36923098
[TBL] [Abstract][Full Text] [Related]
26. A PRISMA meta-analysis for diagnostic value of microRNA-21 in head and neck squamous cell carcinoma along with bioinformatics research.
Li CX; Su Y; Wang ZY; Liu H; Gong ZC; Zhao HR
Oral Maxillofac Surg; 2024 Jun; 28(2):739-752. PubMed ID: 38038839
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of CDKN2A in head and neck squamous cell carcinoma via pathomics and machine learning.
Wang Y; Zhou C; Li T; Luo J
J Cell Mol Med; 2024 May; 28(9):e18394. PubMed ID: 38751024
[TBL] [Abstract][Full Text] [Related]
28. m7G-related genes-NCBP2 and EIF4E3 determine immune contexture in head and neck squamous cell carcinoma by regulating CCL4/CCL5 expression.
Xu X; Zhao Y; Ying Y; Zhu H; Luo J; Mou T; Zhang Z
Mol Carcinog; 2023 Aug; 62(8):1091-1106. PubMed ID: 37067401
[TBL] [Abstract][Full Text] [Related]
29. Mining of gene modules and identification of key genes in head and neck squamous cell carcinoma based on gene co-expression network analysis.
Zhao Q; Zhang Y; Zhang X; Sun Y; Lin Z
Medicine (Baltimore); 2020 Dec; 99(49):e22655. PubMed ID: 33285674
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics-Assisted Extraction of All PCa miRNAs and their Target Genes.
Ramu A; Chinnappan J
Microrna; 2024; 13(1):33-55. PubMed ID: 38284737
[TBL] [Abstract][Full Text] [Related]
31. Potential Role of the Intratumoral Microbiota in Prognosis of Head and Neck Cancer.
Hamada M; Inaba H; Nishiyama K; Yoshida S; Yura Y; Matsumoto-Nakano M; Uzawa N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895136
[TBL] [Abstract][Full Text] [Related]
32. Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for Head and Neck Squamous Cell Carcinoma.
Wu ZH; Yun-Tang ; Cheng Q
Cell Transplant; 2020; 29():963689720929308. PubMed ID: 32452220
[TBL] [Abstract][Full Text] [Related]
33. IGF2BP2 promotes head and neck squamous carcinoma cell proliferation and growth via the miR-98-5p/PI3K/Akt signaling pathway.
Yu D; Xiao Z; Zou Z; Lin L; Li J; Tan J; Chen W
Front Oncol; 2023; 13():1252999. PubMed ID: 37936610
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.
Fan S; Zheng H; Zhan Y; Luo J; Zang H; Wang H; Wang W; Xu Y
Crit Rev Oncol Hematol; 2024 Jan; 193():104223. PubMed ID: 38036157
[TBL] [Abstract][Full Text] [Related]
35. Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer.
Nguyen PT; Shimojukkoku Y; Kajiya Y; Oku Y; Tomishima A; Shima K; Sasahira T
PLoS One; 2024; 19(5):e0300446. PubMed ID: 38820302
[TBL] [Abstract][Full Text] [Related]
36. Identification of protein methyltransferases 5 associated with ferroptosis and immune cell infiltration of head and neck squamous cell carcinoma.
Zhang X; Liu Q; Wang L; Peng Q
Aging (Albany NY); 2024 Apr; 16(8):7426-7436. PubMed ID: 38663941
[TBL] [Abstract][Full Text] [Related]
37. Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol.
Shaw P; Raymond G; Senthilnathan R; Kumarasamy C; Baxi S; Suresh D; Shetty S; Ram M R; Chandramoorthy HC; Sivanandy P; Samiappan S; Rajagopal M; Krishnan S; Jayaraj R
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946979
[No Abstract] [Full Text] [Related]
38. Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact.
Takeuchi T; Kawasaki H; Luce A; Cossu AM; Misso G; Scrima M; Bocchetti M; Ricciardiello F; Caraglia M; Zappavigna S
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456271
[TBL] [Abstract][Full Text] [Related]
39. MRI radiomics in head and neck cancer from reproducibility to combined approaches.
Corti A; Cavalieri S; Calareso G; Mattavelli D; Ravanelli M; Poli T; Licitra L; Corino VDA; Mainardi L
Sci Rep; 2024 Apr; 14(1):9451. PubMed ID: 38658630
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer.
Kabzinski J; Maczynska M; Majsterek I
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
